Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 2
134
Views
4
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Metabolites identification and species comparison of Oroxylin A, an anti-cancer flavonoid, in vitro and in vivo by HPLC-Q-TOF-MS/MS

, , , , , , , , , , , & show all
Pages 165-176 | Received 02 Nov 2021, Accepted 30 Nov 2021, Published online: 29 Mar 2022

References

  • Feng R, Zhang X, Yin J, Zhang Y, Ma Y, Zhang X, Zhang L, Li D. 2021. A comprehensive study of the metabolism of flavonoid oroxin B in vivo and in vitro by UHPLC-Q-TOF-MS/MS. J Pharm Biomed Anal. 197:113905.
  • Gan L, Ji J, Wang L, Li Q-Y, Zhang C-F, Wang C-Z, Yuan C-S. 2020. Identification of the metabolites in normal and AA rat plasma, urine and feces after oral administration of Daphne genkwa flavonoids by LC-Q-TOF-MS spectrometry. J Pharm Biomed Anal. 177:112856.
  • Hanioka N, Isobe T, Tanaka-Kagawa T, Ohkawara S. 2020. Wogonin glucuronidation in liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice. Xenobiotica. 50(8):906–912.
  • Ji Y, Han J, Lee N, Yoon J-H, Youn K, Ha HJ, Yoon E, Kim DH, Jun M. 2020. Neuroprotective effects of Baicalein, Wogonin, and Oroxylin A on amyloid beta-induced toxicity via NF-kappaB/MAPK pathway modulation. Molecules. 25(21):5087–5102.
  • Jiang P, Ma Y, Gao Y, Li Z, Lian S, Xu Z, Jiang W, Tian X, Huang C. 2016. Comprehensive evaluation of the metabolism of genipin-1-β-d-gentiobioside in Vitro and in vivo by using HPLC-Q-TOF. J Agric Food Chem. 64(27):5490–5498.
  • Jiao Q, Xu L, Jiang L, Jiang Y, Zhang J, Liu B. 2020. Metabolism study of hesperetin and hesperidin in rats by UHPLC-LTQ-Orbitrap MS n. Xenobiotica. 50(11):1311–1322.
  • Lu L, Guo QL, Zhao L. 2016. Overview of Oroxylin A: A promising flavonoid compound. Phytother Res. 30(11):1765–1774.
  • Murota K, Nakamura Y, Uehara M. 2018. Flavonoid metabolism: the interaction of metabolites and gut microbiota. Biosci Biotechnol Biochem. 82(4):600–610.
  • Ren G, Chen H, Zhang M, Yang N, Yang H, Xu C, Li J, Ning C, Song Z, Zhou S, et al. 2020a. Pharmacokinetics, tissue distribution and excretion study of Oroxylin A, Oroxylin A 7-O-glucuronide and Oroxylin A sodium sulfonate in rats after administration of Oroxylin A. Fitoterapia. 142:104480.
  • Ren G, Chen H, Zhang M, Yang N, Yang H, Xu C, Li J, Ning C, Song Z, Zhou S, et al. 2020b. Determination of oroxylin A, oroxylin A 7-O-glucuronide, and oroxylin A sodium sulfonate in beagle dogs by using UHPLC MS/MS application in a pharmacokinetic study. J Sep Sci. 43(12):2290–2300.
  • Shen M, Guo M, Wang Z, Li Y, Kong D, Shao J, Tan S, Chen A, Zhang F, Zhang Z, et al. 2020. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis. Int Immunopharmacol. 85:106637.
  • Sun XHu, Chang X, Wang Y, Xu B, Cao X. 2019. Oroxylin A suppresses the cell proliferation, migration, and EMT via NF-kappaB signaling pathway in human breast cancer cells. Biomed Res Int. 2019:9241769.
  • Underhill GH, Khetani SR. 2018. Advances in engineered human liver platforms for drug metabolism studies. Drug Metab Dispos. 46(11):1626–1637.
  • Wang X, He B, Shi J, Li Q, Zhu H-J. 2020. Comparative proteomics analysis of human liver microsomes and S9 fractions. Drug Metab Dispos. 48(1):31–40.
  • Wu J, Zhong QQ, Wang TY, et al. 2021. MS-based metabolite analysis of two licorice chalcones in mice plasma, bile, feces, and urine after oral administration. Biomed Chromatogr. 35(3):e4998–e5009.
  • Xie C, Zhong DF, Chen XY. 2013. A fragmentation-based method for the differentiation of glutathione conjugates by high-resolution mass spectrometry with electrospray ionization. Anal Chim Acta. 788:89–98.
  • Yang H, Li J, Zheng Y, Zhou L, Tong S, Zhao B, Cai W. 2016. Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A. Sci Rep. 6:21604.
  • Yuan L, Liang C, Diao X, Cheng X, Liao M, Zhang L. 2018. Metabolism studies on hydroxygenkwanin and genkwanin in human liver microsomes by UHPLC-Q-TOF-MS. Xenobiotica. 48(4):332–341.
  • Zeng X, Su W, Zheng Y, Liu H, Li P, Zhang W, Liang Y, Bai Y, Peng W, Yao H, et al. 2018. UFLC-Q-TOF-MS/MS-based screening and identification of flavonoids and derived metabolites in human urine after oral administration of Exocarpium Citri Grandis extract. Molecules. 23(4):895–909.
  • Zhang Q, Cong D, An D, Fan A, Liu Q, Yi Y, Song Z, Chen X, Lu Y, Zhao D, et al. 2018. Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC-MS/MS: cellular pharmacokinetic study to indicate anti-cancer mechanisms. J Pharm Biomed Anal. 154:364–372.
  • Zhang W, Xu L-L, Yu X, Jiang Y-Y, Zhang J-Y, Liu B. 2020. Characterization and identification of the metabolites of Menthae Haplocalycis Herba water extracts in rat plasma, urine, and feces by ultra-high performance liquid chromatography with linear ion trap-Orbitrap mass spectrometry. J Sep Sci. 43(6):1051–1062.
  • Zhao Y, Zhu Q, Bu X, Zhou Y, Bai D, Guo Q, Gao Y, Lu N. 2020. Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis. Redox Biol. 29:101392.
  • Zhou Q, Zheng Z, Xia B, Tang L, Lv C, Liu W, Liu Z, Hu M. 2010. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of Wogonin and Oroxylin A by human liver and intestinal microsomes. Pharm Res. 27(8):1568–1583.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.